Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.23.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
shares in Thousands, $ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Allowance for accounts receivable $ 2,164 $ 2,154
Common stock, par value $ 0.001 $ 0.001
Series F Preferred stock, par value $ 0.001 $ 0.001
Series F Preferred stock, shares authorized 18 18
Series F Preferred stock, shares issued 0 0
Series F Preferred stock, shares outstanding 0 0
Common stock, shares authorized 180,000 180,000
Common stock, shares issued 7,723 6,149
Common stock, shares outstanding 7,721 6,147